Sk Bioscience Co Stock Price To Earnings To Growth
| 302440 Stock | 55,500 900.00 1.65% |
SK Bioscience Co fundamentals help investors to digest information that contributes to SK Bioscience's financial success or failures. It also enables traders to predict the movement of 302440 Stock. The fundamental analysis module provides a way to measure SK Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SK Bioscience stock.
302440 |
SK Bioscience Co Company Price To Earnings To Growth Analysis
SK Bioscience's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, SK Bioscience Co has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The price to earnings to growth for all Republic of Korea stocks is 100.0% higher than that of the company.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
302440 Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.47 % | |||
| Current Valuation | 5.52 T | |||
| Shares Outstanding | 76.78 M | |||
| Shares Owned By Insiders | 69.27 % | |||
| Shares Owned By Institutions | 4.61 % | |||
| Price To Book | 4.01 X | |||
| Price To Sales | 8.39 X | |||
| Revenue | 929 B | |||
| Gross Profit | 570.03 B | |||
| EBITDA | 493.33 B | |||
| Net Income | 355.14 B | |||
| Total Debt | 35.5 B | |||
| Cash Flow From Operations | 536.59 B | |||
| Earnings Per Share | 917.26 X | |||
| Target Price | 82083.0 | |||
| Market Capitalization | 5.56 T | |||
| Total Asset | 2.11 T | |||
| Z Score | 93.6 | |||
| Net Asset | 2.11 T |
About SK Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SK Bioscience Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SK Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SK Bioscience Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with SK Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SK Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SK Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving together with 302440 Stock
Moving against 302440 Stock
The ability to find closely correlated positions to SK Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SK Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SK Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SK Bioscience Co to buy it.
The correlation of SK Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SK Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SK Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SK Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in 302440 Stock
SK Bioscience financial ratios help investors to determine whether 302440 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 302440 with respect to the benefits of owning SK Bioscience security.